United by a commitment to innovation, brothers Tan Min-Liang and Tan Min-Han reflect on their entrepreneurial journeys, the cultures they have built, and how family has driven their pursuit of excellence
The pursuit of health and happiness influences the decisions we make and the goals we set for ourselves. While good health lays the foundation for a fulfilling life, happiness gives it meaning and purpose.
Few demonstrate this balance more distinctly than Tan Min-Liang and Tan Min‑Han. As co-founder and CEO of gaming lifestyle company Razer, Min-Liang focuses on happiness—creating immersive experiences that bring joy to gamers. His elder brother Min-Han, a medical oncologist and clinical cancer geneticist, is dedicated to health as the founding CEO and medical director of Lucence, a precision oncology company advancing the frontiers of medical science in earlier cancer detection and effective treatment.
Though their industries and personalities could not be more different—as reflected in their outfits for the photo shoot for this story, with Min-Liang in his signature T-shirt, jeans and sneakers, and Min-Han decidedly more formal in a dress shirt and pants, jacket and tie optional—the brothers are bound by a commitment to innovation, a sense of purpose and a vision of using technology to elevate the human experience.
Read more: How Razer and Tan Min-Liang stepped up and led the fight against the Covid-19 crisis

Above Tan Min-Liang and Tan Min‑Han on the cover of the June 2025 issue of Tatler Singapore
Min-Liang co-founded Razer in 2005 with a vision of creating better gear for gamers. What started as a company with a focus on high‑performance gaming mice (its first product was the Boomslang, which set new standards in performance as well as design) soon evolved into a full‑fledged gaming lifestyle brand. Today, Razer stands as a global leader, not only in gaming peripherals, but also in systems, software and financial services, all designed for a hyper-connected digital generation. Anchored by the ethos “for gamers, by gamers” and a commitment to community-driven innovation, the company has evolved to become a cultural phenomenon.
“From gaming to pop culture trends, we understand what gamers want because we’re gamers ourselves and we listen closely to our community,” says Min-Liang. He shares, as an example, how mobile gaming has become a key part of the industry’s evolution—and a central pillar of Razer’s business strategy. “We’ve seen growing demand from gamers who want to play every game everywhere and are committed to exploring this immense potential as we expand the Razer ecosystem to deliver hardware, software and services that enhance the performance, comfort and immersive experiences.”
In recent years, the company has made remarkable progress in enabling mobile devices to deliver console‑like gaming experiences. Both the Razer Kishi Ultra, a mobile controller for smartphones and tablets launched in 2024, and the Razer PC Remote Play, a game-streaming feature recently debuted this April, allow gamers to access all their games on the go, unlocking new possibilities across Android, iOS and Windows devices. “We’re excited when our [gaming] community enjoys our products. Their feedback is invaluable as we continue to enhance our offerings,” shares Min-Liang. “This close connection and our commitment to listening to their needs drive our innovation and help us stay ahead of industry trends.”

Above Tan Min-Liang co-founded Razer in 2005 with a vision of creating better gear for gamers
A CLEAR CALLING
Min-Han, in contrast, has charted a more clinical yet equally ambitious course. His work focuses on non‑invasive diagnostics and precision oncology, developing technologies to detect and treat diseases, particularly cancers. “As a cancer doctor and geneticist, it’s heartbreaking to see patients when their cancer is already advanced, as there’s often little we can do,” he says. Cancer is a leading cause of death worldwide, with the World Health Organization reporting an estimated 10 million lives lost to it in 2020 alone—roughly one in six deaths. “And that’s 10 million too many,” Min‑Han states.
This is the driving force behind Lucence’s work to improve patient outcomes through earlier cancer detection and personalised therapy. The company does this through liquid biopsies—simple blood tests that provide a less-invasive alternative to traditional biopsies, which often involve surgery or radiation-based imaging.
Lucence achieved a major breakthrough in February 2023, becoming the first Asian-headquartered company to receive coverage for its flagship LiquidHallmark test under Medicare, the US government-funded healthcare programme. The Singapore-developed test provides insights that can inform treatment decisions and track tumour changes over time for 15 different cancers, including lung, breast and colon cancer. “Doctors can choose treatments that specifically target the unique genetic changes driving the cancer’s growth. By matching the right therapy to the individual’s tumour, patients can receive more effective care with fewer side effects, improving their overall quality of life,” Min‑Han explains.
In May that same year, Lucence launched LucenceInsight, a groundbreaking early cancer detection tool that analyses a single blood sample to screen for indicators of over 50 types of cancer. “By detecting cancer before symptoms arise, it enables earlier treatment, potentially leading to better outcomes,” says Min-Han. The test is currently available in clinics and screening centres across Singapore and Hong Kong.
Earlier this year, Lucence announced a strategic collaboration with Mayo Clinic Laboratories, a leader in diagnostics that operates primarily in the US and has an international presence, to expand access to cutting‑edge cancer testing services globally. Alongside its laboratories in Singapore and Palo Alto in California, Lucence’s innovative LiquidHallmark liquid biopsy technology is now accessible worldwide through Mayo Clinic Laboratories and its healthcare partners, enhancing the global landscape of oncology diagnostics for better decision‑making and patient outcomes.
“With the US healthcare sector exceeding US$4 trillion annually, and Medicare covering more than 65 million lives, this move grants us access to a vast patient pool and positions us within a key innovation hub. The [estimated] 1.9 million [new] cancer diagnoses in the US [in 2022] highlights the market’s potential,” says Min‑Han. “This expansion validates our technology and fosters collaborations with leading institutions. Globally, we aim to revolutionise cancer care by democratising diagnostics, potentially impacting the [millions of ] annual cancer deaths worldwide.”
Having made significant inroads into the US—the world’s largest healthcare market and a hub for leading pharmaceutical companies—Lucence has come a long way since its beginnings in 2016 as a spin-off company for Singapore’s Agency for Science, Technology and Research, where Min-Han led a research laboratory for six years. “Building the technology was just the beginning,” he says. “Changing the world around it is a life’s mission.”
One of the key challenges ahead lies in navigating the complex regulatory landscapes of different countries while scaling operations to meet growing demand. To tackle this, Min-Han draws on the steadfast support of his younger brother, Min-Liang, whose keen business insight and investment support have been instrumental to Lucence’s growth.
“As an investor in Lucence, I strongly believe in its mission to revolutionise cancer detection and improve patient outcomes,” says Min‑Liang, who regularly connects with the team, offering guidance and support on business strategy, fundraising efforts and technological advancements. He shares that his own journey with Razer—and deep understanding of the power of technology in transforming industries—has taught him “the importance of fostering innovation and understanding customer needs to create a brand that resonates with a global target audience”.
“Being Min‑Han’s brother,” he goes on to say, “adds another layer to my commitment to Lucence. Witnessing his dedication to this critical cause first‑hand fuels my passion to see the vision come to life. I actively participate in discussions, provide emotional support and celebrate milestones alongside him.”
The Tan brothers’ approach to innovation is deeply influenced by their upbringing, which emphasised discipline, critical thinking and a thirst for knowledge. These values were instilled in them from an early age by their parents, who prioritised education and encouraged curiosity. “Our parents emphasised two principles: work hard and be useful to others,” Min-Han shares. “They did their best to expose me to science, arts and sports, and succeeded in instilling an enduring interest in hiking. I did well in school—topping the national exams at age 12—but often found it more interesting to pursue abstract questions around science and history. I like solving difficult questions, particularly when information is sparse and even conflicting.”

Above Tan Min-Han is a medical oncologist and clinical cancer geneticist
Although their parents never charted specific career paths for the brothers and their two elder sisters, all four chose to pursue either medicine or law—yes, even Min‑Liang, who practised law for several years before making his mark as an entrepreneur. Intriguingly, it was Min‑Han who got him interested in computer games. “I’ve played my fair share of games with Min‑Liang when we were younger, but I can’t confess to being a gamer now,” says Min‑Han. “He was more interested in programming, while I was more interested in playing games,” Min‑Liang quips.
“As a gamer, I’ve always approached challenges with a mindset of perseverance and continuous improvement,” reveals Min‑Liang, attributing this in part to his family, who taught him to “stay true to the course, focus on my goals and always be passionate about what I do”. “One of the most surprising lessons I’ve learnt is how this gamer mentality translates so well into entrepreneurship: the ability to adapt, learn from failures and keep pushing forward has been invaluable,” adds the avid gamer, who mentions that passion is also a driving force. “When you’re passionate about what you do, it doesn’t feel like work— it’s an exciting journey filled with opportunities to create and innovate.”
While the brothers are navigating different paths, they share a commitment to innovation—a dedication that has served them well, especially in the face of the challenges that come with entrepreneurship. Both have worked hard to cultivate cultures of innovation within their teams, their approaches shaped by the unique demands of their industries.
Lucence prioritises open communication and cross‑functional collaboration, encouraging diverse perspectives that contribute to novel solutions. “We empower our employees by giving them autonomy and resources to experiment, understanding that innovation often stems from calculated risks and learning from mistakes,” says Min-Han. “We invest heavily in continuous learning and development, providing access to cutting-edge technologies and training. We also celebrate and reward creative contributions, fostering a culture where innovation is valued and recognised.”
Razer, meanwhile, fosters innovation while honouring the spirit of creativity that has been at the heart of its success through internal programmes that recognise and reward employees whose innovative ideas lead to patentable inventions. “As of December 2024, we’ve filed nearly 2,700 invention and design patents across a wide range of products and services—of which an impressive 80 per cent have been granted,” Min‑Liang shares. “These contributions continue to push Razer to new heights and have a tangible impact on the company’s success.”

Above Both Min‑Liang and Min‑Han are determined to make a lasting impact on the world
Beyond delivering innovative products, Razer is always looking for opportunities to collaborate with industry stakeholders to expand its offerings. “Today, it’s mobile gaming and artificial intelligence (AI); tomorrow, it could be Web3 or any new technologies and platforms that further enhance the gaming experience,” expounds Min‑Liang, who is also the creative director responsible for directing and overseeing the design and development of all the products at the company. “Ultimately, Razer will be defined by our ability to adapt to the evolving needs of gamers and the gaming industry while staying true to our core values and ethos. We’ll continue pushing the boundaries of what’s possible in gaming and beyond to redefine the future.”
In case you missed it: The Singapore startup using AI to transform traditional health screenings
To that end, Min‑Liang sees “AI as a tool at the service of the creative minds crafting the experiences we enjoy every day”, enthusing that “we want to empower game designers, game developers and gamers to create better and more interactive experiences”. He elaborates: “It’s fascinating how rapidly AI has advanced—I often tell my team that if you’re not using AI on a daily basis, you’re falling behind. And this can be seen with the advances that we’re making in AI for the gaming industry. Razer has embraced AI, and we’ve used the technology to create some incredible tools for both developers and gamers.” Case in point: its new Wyvrn game developer platform launched this March, which is designed to empower game creators with tools to transform the player experience and streamline game development processes via a single development key.
Whether it is by creating products that enhance the gaming experience or by developing technologies that save lives, both Min‑Liang and Min‑Han are determined to make a lasting impact on the world. For them, the pursuit of health and happiness is not just a business—it is a way of life.
Credits
Photography: Darren Gabriel Leow
Styling: Adriel Chiun
Hair: Leong using Kevin Murphy
Grooming: Alif Alwee at Bobbi Brown





